RFMN in Combination With 1927 nm Thulium Laser for Treating Photoaged Skin

Last updated: May 20, 2024
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Overall Status: Active - Recruiting

Phase

N/A

Condition

Skin Aging

Treatment

radiofrequency microneedling monotherapy

radiofrequency microneedling combined with 1927 nm thulium laser

Clinical Study ID

NCT06029725
03-23
  • Ages > 30
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The appearance of the aging skin is influenced by different factors including by the reduced elasticity and increased laxity of the skin, the decreasing volume as well as pigmentation disorders and dilated vascular markings. Currently, there are different methods available to treat the aging skin. Here, the combined treatment of radiofrequency micro needling (RFMN) and thulium laser has been commonly used in clinical practice.

The aim of this clinical study is to investigate the efficacy, patient satisfaction, safety of RFMN and thulium laser treatment in patients with facial, age-related skin laxity, wrinkles, and pigmented lesions.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Men and women from the age of 30 years

  • good general condition, no relevant previous diseases

  • Presence of wrinkles, dermatochalasis on the face, pigment spots, which are anindication for RFMN and thulium laser or comparable methods

  • Cognitive ability and willingness to give consent (informed consent)

  • Be willing and able to attend follow-up visits

Exclusion

Exclusion Criteria:

  • Age < 30 years

  • Pregnancy or breastfeeding

  • Excessive subcutaneous fatty tissue under the cheeks

  • Significant scarring of the region to be treated

  • open wounds or lesions of the region to be treated

  • Severe or cystic facial acne

  • Metallic implants in the face or neck region

  • Mental illnesses (psychoses, body perception disorders)

  • Use of isotretinoin or other retinoids, psychotropic drugs, coumarins or heparins inthe last 2 weeks

  • Fillers in the region to be treated < 4 weeks prior and during the study period

  • Resurfacing (fractional, ablative, nonablative) of the region of interest < 2 monthsprior and during the study period

  • Plastic aesthetic procedures or other surgical procedures < 6 months prior andduring the study period

  • Tendency to have excessive scarring

  • Lack of informed consent

Study Design

Total Participants: 35
Treatment Group(s): 2
Primary Treatment: radiofrequency microneedling monotherapy
Phase:
Study Start date:
December 15, 2023
Estimated Completion Date:
March 01, 2025

Connect with a study center

  • University Medical Center Hamburg-Eppendorf

    Hamburg, 20251
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.